Table 3. Self-Reported and TES Measures of Other Drug Use by Behavioral Treatment Group by Treatment Phase.

Drug	Measure*	Treatment Phase	CBT	CM	CBT+CM	NT
Amphetamines	ASI	Screening	0.7 (3.0)	0.3 (0.8)	1.6 (4.8)	0.4 (1.0)
	TES	Behavioral Treatment Phase	0.95 (.16)	.91 (.19)	.92 (.20)	.91 (.21)
	ASI	End of Behavioral Treatment Phase	.09 (.62)	1.08 (3.27)	1.07 (6.96)	.69 (2.13)
	TES	Medication-Only Treatment Phase	.96 (.13)	.94 (.14)	.89 (.23)	.91 (.23)
Cannabis	ASI	Screening	5.6 (9.8)	5.5 (9.8)	2.1 (5.4)	6.8 (10.4)
	TES	Behavioral Treatment Phase	.72 (.36)	.78 (.33)	.83 (.31)	.62 (.43)
	ASI	End of Behavioral Treatment Phase	5.71 (9.34)	4.73 (9.41)	1.86 (4.32)	9.47 (12.69)
	TES	Medication-Only Treatment Phase	.72 (.40)	.81 (.33)	.88 (.29)	.65 (.43)
Cocaine	ASI	Screening	1.4 (4.8)	3.4 (8.1)	1.6 (3.0)	1.2 (3.1)
	TES	Behavioral Treatment Phase	.91 (.19)	.79 (.34)	.74 (.35)	.89 (.15)
	ASI	End of Behavioral Treatment Phase	.83 (3.2)	2.01 (4.93)	2.25 (5.78)	.53 (1.60)
	TES	Medication-Only Treatment Phase	.89 (.24)	83 (.33)	.81 (.34)	.86 (.24)
Sedatives	ASI	Screening	3.4 (7.5)	4.1 (8.6)	3.1 (5.7)	2.5 (5.3)
	TES	Behavioral Treatment Phase	.78 (.29)	.79 (.29)	.76 (.32)	.83 (.27)
	ASI	End of Behavioral Treatment Phase	5.4 (9.4)	3.42 (7.76)	4.44 (7.89)	4.24 (8.79)
	TES	Medication-Only Treatment Phase	.73 (.34)	.82 (.29)	.74 (.38)	.77 (.35)

^*ASI = self-reported days of use in the last 30 days; TES = Treatment Effectiveness Score